期刊文献+

端粒酶抑制剂与肝癌治疗的研究进展

下载PDF
导出
作者 张明磊
出处 《临床肝胆病杂志》 CAS 北大核心 2001年第4期198-200,共3页 Journal of Clinical Hepatology
  • 相关文献

参考文献8

  • 1[1]Feng J ,Fun K WD,Wang SS,et al. The RNA component of human telomerase [ J ]. Science, 1995,269:1236.
  • 2[2]Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and duringimmortalization [J]. Cell, 1997,90: 785.
  • 3[3]Weinrich SL, Pruzan R, Mal, et al. Reconstitution of human telomere with the template RNA component Htr and the catalytic protein subunit [J ]. Nat Genet, 1997,17: 498.
  • 4[4]Strahl C, Blackburn EH. Effects of reverse t ranscriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines[J]. Mol Cell Biol, 1996,16: 53.
  • 5[5]Yegorov YE, Chemov DN, Akimov SS, et al. Reverse transcriptase inhibitors suppress telomerase function and induce senescence like processes in cultured mouse fibroblasts[J ] .FEBS Lett, 1996, 389:115.
  • 6[6]Ku WC, Cheng A J, Wang TC. Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture [J].Biochem Biophys Res Commun, 1997,241:730.
  • 7[7]Sharma HW, Sokoloski JA, Perez JR, et al. Differentiation of immortalcells inhibits telomerase activity [ J ]. Proc Natl Acad Sci USA,1995,92:12343.
  • 8[8]Zhu X, Kurmar R, Mandal M, et al. Cell cycle-dependent modulation of telomerase activity in tumor cells[J ] .Proc Natl Acad Sci USA,1996,93: 6091.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部